Apomorphine in Severe Brain-injured Patients — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Disorder of Consciousness trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(4 sites)

Belgium

University of Liege, Liège, Liege

Hôpital Valdor - ISoSL, Liège, Liège

Centre Hospitalier Neurologique William Lennox, Ottignies-Louvain-la-Neuve

Spain

VITHAS, Valencia

Key details

Phase

Large-scale testing

Sponsor

University of Liege

Collaborators

Centre Hospitalier Neurologique William Lennox (Belgium), Hôpital Valdor - ISoSL (Belgium)

Enrollment target

~48 participants

Started

June 2021

Primary completion

December 2026

Age range

18 Years – 80 Years

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

Apomorphine in Severe Brain-injured Patients — Stella